Literature DB >> 1766709

Pseudooutbreak of Candida guilliermondii fungemia in a neonatal intensive care unit.

P Yagupsky1, R Dagan, M Chipman, A Goldschmied-Reouven, E Zmora, M Karplus.   

Abstract

During a 3-week period multiple blood cultures obtained from 14 Neonatal Intensive Care Unit infants and 3 Newborn Unit babies grew Candida guilliermondii, a yeast rarely associated with infections in humans. At the time of detection of positive cultures, most infants had been hospitalized for days or weeks for serious perinatal conditions and treated with antibiotics and intravenous hyperalimentation. Two critically ill premature infants from whom the yeast was isolated were given amphotericin B. In 7 other infants, however, yeasts were recovered on the day of birth, raising the question of pseudofungemia. Exhaustive interrogation on the blood culture practices revealed that when drawing blood for a culture from small infants, "butterfly" needles were often flushed with a diluted heparin solution to prevent blood clotting. Culture of a single lot of diluted heparin vials, prepared at the hospital pharmacy and distributed to the Neonatal Intensive Care Unit and Newborn Unit shortly before the onset of the epidemic, grew between 10,000 and 15,000 colony-forming units of Candida guilliermondii/ml. Removal of contaminated heparin vials and discontinuation of heparinization of needles used for blood cultures resulted in cessation of the epidemic. The present outbreak illustrates the difficulties in recognizing pseudoinfections in sick premature infants and the importance of intensive investigation and intervention during such an outbreak.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1766709     DOI: 10.1097/00006454-199112000-00010

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

1.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

2.  Evidence for a pseudo-outbreak of Candida guilliermondii fungemia in a university hospital in Brazil.

Authors:  Eduardo Alexandrino Servolo Medeiros; Timothy J Lott; Arnaldo Lopes Colombo; Patrício Godoy; Ana Paula Coutinho; Monica Santos Braga; Marcio Nucci; Mary E Brandt
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

3.  Killing kinetics of caspofungin, micafungin, and amphotericin B against Candida guilliermondii.

Authors:  Emilia Cantón; Javier Pemán; Macrina Sastre; Mónica Romero; Ana Espinel-Ingroff
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

4.  Heparin is not required for peripheral intravenous locks in neonates.

Authors:  K Brown; J S Tay-Uyboco; D D McMillan
Journal:  Paediatr Child Health       Date:  1999-01       Impact factor: 2.253

5.  Candida guilliermondii fungemia in patients with hematologic malignancies.

Authors:  Corrado Girmenia; Giampaolo Pizzarelli; Francesco Cristini; Francesco Barchiesi; Elisabetta Spreghini; Giorgio Scalise; Pietro Martino
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

6.  Investigation of a Candida guilliermondii Pseudo-outbreak Reveals a Novel Source of Laboratory Contamination.

Authors:  James E Kirby; Westyn Branch-Elliman; Mary T LaSalvia; Lorinda Longhi; Matthew MacKechnie; Grigoriy Urman; Linda M Baldini; Fatima R Muriel; Bernadette Sullivan; David S Yassa; Howard S Gold; Trevor K Wagner; Daniel J Diekema; Sharon B Wright
Journal:  J Clin Microbiol       Date:  2017-01-18       Impact factor: 5.948

7.  Nosocomial cluster of Candida guillermondii fungemia in surgical patients.

Authors:  L Masala; R Luzzati; L Maccacaro; L Antozzi; E Concia; R Fontana
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-18       Impact factor: 3.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.